Information Provided By:
Fly News Breaks for March 7, 2019
KIDS
Mar 7, 2019 | 14:27 EDT
Piper Jaffray analyst Matt O'Brien noted that the midpoint of OrthoPediatrics's 2019 revenue growth guidance of 21-23% was above the consensus 21% target and he views the guidance as "prudently set for a year of beat and raises" given the company's strong pipeline and expanding sales force. O'Brien keeps an Overweight rating on OrthoPediatrics shares, which are up 65c, or 1.7%, to $39.60 in afternoon trading.
News For KIDS From the Last 2 Days
There are no results for your query KIDS